I’ve not seen anything posted on here about this stock and wondered what everyone’s thoughts were?
1 Like
With this hanging in the balance I would personally be very wary of getting involved. Purely my own opinion. DYOR and good luck.
Bausch, Assertio, Lupin must face antitrust claims over diabetes drug Glumetza | Reuters
A post was merged into an existing topic: Assertio Therapeutics